Introduction
============

The porcine reproductive physiology is a clear and valuable model for studying and developing the knowledge in follicle growth and maturation of the oocyte. Moreover, it gives lots of information that might be implemented in human research, taking into account the relevant similarity of reproduction between the species. The past and recent animal research gave rise to the basics of embryology and implemented many techniques in assisted reproduction. The oocyte development and ovulation are one of the most important processes in mammalian reproduction, though it gives the opportunity to fertilize and transfer genes to a new entity. Nevertheless, growth, differentiation and maturation of the oocyte and surrounding structures still remains a subject of inquiring debate. Literature suggests, that oocyte itself, plays an essential role in regulatory mechanisms of its growth and development, influencing and being influenced by surrounding granulosa cells via specific gap junctions. These mechanisms are regulated by expression of particular genes and their biochemical signaling pathways, presence of specific molecules and growth and differentiation factors ([@b1-mmr-21-03-1537]--[@b5-mmr-21-03-1537]). Oocyte maturation consists of numerous rearranges in cell nucleus and cytoplasm, which are essential to finalize its competence to fertilize. Nuclear maturity is strictly conjoined with resume and finish of first meiotic division and entrance into second one, arrested in metaphase II, until contact with spermatozoon. The initiation of final maturation is present in antral-dominant follicles and is based on the mid-cyclic LH surge or administration of human chorionic gonadotropin (hCG). However, as mentioned, mechanisms of oocyte maturation *in vivo* are still under investigation, therefore an animal *in vitro* models provide insight into these complicated and sensitive cross-linked actions, comprising regulation of gene expression, transcription and macromolecule metabolic processes. The adequate gene expression and storage of macromolecules seems to be crucial for protein biosynthesis during pre- and periimplantation stages of embryo development ([@b6-mmr-21-03-1537]).

The mentioned, bi-directional communication between the oocyte and accompanying cumulus cells is necessary for growth, development and function of the whole cumulus-oocyte complex (COC), but it has also been published, that the oocyte is the crucial cell determining the direction of differentiation and the function of the granulosa cells surrounding it ([@b1-mmr-21-03-1537]). It secretes factors, such as growth and differentiation factor 9 (GDF9), bone morphogenetic protein 15 (BMP15) and possibly many others, regulating proliferation, apoptosis, expansion luteinisation and metabolism of GCs ([@b7-mmr-21-03-1537]). However, transcriptomic profiles of exclusively expressed either in granulosa cells or oocytes have been hardly studied. We investigated transcriptome profile of porcine oocytes before and after *in vitro* culture, assuming, that oocyte itself plays a crucial role in self-development and early embryo evolution. The results obtained are advancing our knowledge about oocyte transcriptome changes during *in vitro* culture ([@b8-mmr-21-03-1537]--[@b10-mmr-21-03-1537]).

Materials and methods
=====================

Part of the materials and methods section is based on our previous publications of the same research team, presenting results from the same cycle of studies related to porcine oocytes ([@b11-mmr-21-03-1537]--[@b13-mmr-21-03-1537]).

### Animals

In the present study, pubertal crossbred Landrace gilts (median age of 170, ranging from 150--180 days; median weight of 98 kg, ranging from 95--110 kg) in a total number of 45 were used. The animals were bred under the same conditions, also feeding and housing state of all the animals was identical. The specimen were obtained from a commercial slaughterhouse and the methods of anaesthesia, euthanasia and death verification were compliant to the law of the European Union (European Union Parliament directives 853/2004, 854/2004 and 1099/2009, on the hygiene, quality control, worker qualification and slaughter methods in the meat industry) and Local Laws \[Directives of the Polish Ministry of Agriculture and Countryside Development from 24th of September 2009 (Protection of Slaughtered Animals) and 19th of May 2010 (Qualification of Small-scale Slaughterhouse Working Conditions and Hygiene)\]. All experiments employed in this study were approved by the Local Bioethical Committee of Poznań University of Medical Sciences (resolution no. 32/2012, issued 01.06.2012).

### Collection of porcine ovaries and cumulus-oocyte-complexes (COCs)

After slaughter, the ovaries and reproductive tracts of the animal specimen were recovered and transported to the laboratory within 30 min at 38°C. in 0.9% NaCl, to provide material integrity through transport time. Ovaries of each animal were placed in phosphate buffered saline (PBS) supplemented with 5% fetal bovine serum (FBS; Sigma-Aldrich Co.; Merck KGaA, Darmstadt, Germany) to ensure optimal environment for subsequent oocyte *in vitro* maturation and fertilization. In the next step, single preovulatory large follicles (an estimated diameter greater than 5 mm) were opened (in the number of 300) in a sterile Petri dish by puncturing (a 5-ml syringe and 20-G needle were employed to puncture selected follicles). This operation allows to obtain the cumulus-oocyte complexes (COCs). The COCs extracted from follicles were washed thrice in PBS supplemented with 36 µg/ml pyruvate, 50 µg/ml gentamicin, and 0.5 mg/ml Bovine Serum Albumin (BSA; all ingredients provided by Sigma-Aldrich Co.; Merck KGaA). After collection and washing, an inverted microscope Zeiss, Axiovert 35 (Zeiss, Lübeck, Germany) were used for COCs selection, counting, and morphological evaluation. Subsequently, the scale suggested by Pujol *et al* ([@b14-mmr-21-03-1537]) and Le Guienne *et al* ([@b15-mmr-21-03-1537]) and also described in our previous study were used. Only grade I COCs that exhibited homogeneous cytoplasm and uniform, compact cumulus cells were qualified for the following steps of study, which resulted in a total of 300 grade I oocytes. From the total number of 300 grade I oocytes that were determined BCB^+^. 150 of those were used for analysis as 'Before IVM' with the other directed for *in vitro* maturation ('After IVM').

Ovaries from ten animals were collected and fixed in the Bouin\'s solution for 48 h. Subsequently, tissues were dehydrated and embedded in paraffin wax. Sections of ovaries (3--4 µm) were cut with a semi-automatic rotary microtome (Leica RM 2145, Leica Microsystems, Nussloch, Germany). Then, the paraffin sections were stained with hematoxylin and eosin (H&E) routine procedure, following the steps: Deparaffinization and rehydration, H and staining, and finally, dehydration. Histological sections were evaluated by light microscope and selected pictures were taken with a use of high-resolution scanning technique and Olympus BX61VS microscope scanner (Olympus, Tokyo, Japan).

### Assessment of oocyte developmental competence by BCB test

Measurement of the activity of the glucose-6-phosphate (G6PDH) enzyme, which is responsible for conversion of Brilliant Cresyl Blue (BCB) stain from blue to colourless, was employed to assess oocyte developmental competence. In oocytes that completed their growth, activity of the enzyme decreases significantly, which causes the stain to be immobilized, resulting in blue oocytes (marked BCB^+^). To perform the BCB staining test oocytes were washed twice in modified Dulbecco PBS (DPBSm) (Sigma-Aldrich; Merck KGaA) additionally supplemented with 50 IU/ml penicillin, 50 µg/ml streptomycin (Sigma-Aldrich; Merck KGaA), 0.4% \[w/v\] BSA, 0.34 mM pyruvate, and 5.5 mM glucose. After the initial preparation of oocytes, cells were treated with 13 µM BCB (Sigma-Aldrich; Merck KGaA) diluted in DPBSm at 38.5°C, 5% CO~2~ for 90 min. In the next step oocyte were twice washed in DPBSm. During the washing procedure, the oocytes were examined under an inverted microscope, which allowed for their classification as stained blue (BCB^+^) or colourless (BCB^−^). Immature oocytes, characterized by the presence of a cumulus cells layer, give a negative result in this test, and were used for the downstream analyses as 'Before IVM' group. Whereas, the BCB^+^ COCs to remove cumulus and granulosa cells layer, were incubated with hyaluronidase solution (Sigma-Aldrich; Merck KGaA) for 2 min at 38°C. After removing these additional cells in the 1% sodium citrate buffer, oocytes for further cell culture procedures were obtained.

### In vitro maturation (IVM) of porcine COCs

The oocytes that gave a positive result after the first BCB test were used during IVM procedure. Oocytes were cultured in 500 µl standard porcine IVM culture medium, TCM-199 (tissue culture medium) with Earle\'s salts and L-glutamine, (Gibco BRL Life Technologies; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 2.2 mg/ml sodium bicarbonate (Nacalai Tesque, Inc., Kyoto, Japan), 0.1 mg/ml sodium pyruvate (Sigma-Aldrich; Merck KGaA), 10 mg/ml Bovine Serum Albumin (BSA), (Sigma-Aldrich; Merck KGaA), 0.1 mg/ml cysteine (Sigma-Aldrich; Merck KGaA), 10% (v/v) filtered porcine follicular fluid and gonadotropin supplements at final concentrations of 2.5 IU/ml hCG (human Chorionic Gonadotropin; Ayerst Laboratories, Inc., Philadelphia, PA, USA) and 2.5 IU/ml eCG (equine Chorionic Gonadotropin; Intervet, Whitby, ON, Canada). Each well in Nunclon™Δ 4-well dishes (Thermo Fisher Scientific, Inc.) was covered with mineral oil overlay and placed for the first 22 h of maturation in 38°C under 5% CO~2~. Subsequently, in the same culture conditions for 22 h, a new portion of the maturation medium has been used, however now without hormone supplementation. After maturation, second BCB staining test was performed, with BCB^+^ oocytes used for downstream analyses. Based on visual analysis under inverted microscope, around 70% from the initial pool of cells were determined as BCB^+^. This contributed to obtain the final number around 105 out of the initial 150 of oocytes marked as 'After IVM'.

### RNA extraction from porcine oocytes and reverse transcription

Before the extraction, COCs from both of the experimental groups were denuded with the use of hyaluronidase and glass micropipette to eliminate all of the surrounding somatic cells. Total RNA from all of the samples (both before and after IVM) was isolated according to the method published by Chomczyński and Sacchi ([@b16-mmr-21-03-1537]) employing TRI reagent (Sigma-Aldrich; Merck KGaA). RNA integrity was determined by denaturing agarose gel (2%) electrophoresis, and then, the RNA was quantified by measuring the optical density (OD) at 260 nm (NanoDrop spectrophotometer; Thermo Scientific, Inc.). The RNA samples were re-suspended in 20--40 µl of RNase-free water and stored at −80°C. RNA samples were treated with DNase I and reverse-transcribed into cDNA using RT2 First Strand kit (Qiagen, Hilden, Germany), according to the manufacturer\'s protocol. From each RNA sample, 100 ng of RNA was taken for the following molecular analyses (Microarray and RT-qPCR).

### Microarray expression analysis and statistics

Experiments were performed in three replicates. cDNA obtained was used for biotin labelling and fragmentation using Affymetrix GeneChip^®^ WT Terminal Labeling and Hybridization (Affymetrix, Santa Clara, CA, USA). Biotin-labelled fragments of cDNA (5.5 µg) were hybridized to Affymetrix^®^ Porcine Gene 1.1 ST Array Strip (48°C/20 h). Microarrays were then washed and stained according to the technical protocol using the Affymetrix GeneAtlas Fluidics Station. The array strips were scanned employing Imaging Station of the GeneAtlas System. Preliminary analysis of the scanned chips was performed using Affymetrix GeneAtlas™ Operating Software. The quality of gene expression data was confirmed according to the quality control criteria provided by the software. The obtained CEL files were imported into downstream data analysis software.

To prepare all presented in the manuscript analyses and graphs Bioconductor, based on the statistical R programming language were used. Each CEL file was merged with a description file. In order to correct background, normalize and summarize the raw data, we used Robust Multiarray Averaging (RMA) algorithm.

To determine the statistical significance of the analyzed genes, moderated t-statistics from the empirical Bayes method were performed. The obtained P-value was corrected for multiple comparisons using Benjamini and Hochberg\'s false discovery rate. The selection of significantly altered genes was based on a P\<0.05 and expression higher than two-fold. The differentially expressed gene list (separated for up- and downregulated genes) was uploaded to the DAVID software (Database for Annotation, Visualization and Integrated Discovery). In our work we focused on 27 genes belonging to 'positive regulation of transcription, DNA-dependent', 'positive regulation of gene expression', 'positive regulation of macromolecule metabolic process' and 'positive regulation of transcription from RNA polymerase II promoter' Gene Ontology Biological Process (GO BP) terms.

Subsequently, sets of differentially expressed genes from selected GO BP terms were applied to STRING10 software (Search Tool for the Retrieval of Interacting Genes/Proteins) for interaction prediction. STRING is a huge database containing information about protein/gene interactions, including experimental data, computational prediction methods and public text collections.

In the next step of microarray data analysis, we employed ReactomeFIViz application to the Cytoscape 3.6.0 software. Through the use of this analytical tool the functional interaction between genes that belongs to the chosen GO BP terms were examined.

The ReactomeFIViz app used for location pathways and network patterns that are connected to cancer and other disease types. It allows to run pathway enrichment analysis for a specified gene group, visualizes found pathways with the use of manually laid-out pathway diagrams, as well as to investigate the functional relations between the genes of those pathways, through accessing the Reactome database.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

The RT-qPCR method was performed to confirm and quantitatively validate the results obtained in the analysis of expression microarrays. LightCycler 96 real-time PCR detection system (Roche Diagnostics GmbH, Mannheim, Germany) was used to perform the RT-qPCR reactions. SYBR^®^ Green I detection dye was used during the analyzes, with target cDNA quantified using the relative quantification method. The relative abundance of FOS, VEGFA, ESR1, AR, CCND2, EGR2, ENDRA, GJA1, INHBA transcripts in each sample was standardized to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA level as an internal control. For efficient amplification, 2 µl of previously received cDNA was mixed with 18 µl of RT^2^ SYBR^®^ Green ROX™ qPCR Master Mix (Qiagen Sciences, Inc., Gaithersburg, MD, USA) and sequence-specific primers ([Table I](#tI-mmr-21-03-1537){ref-type="table"}). One RNA repeat from each preparation was processed without the RT-reaction to provide a negative control for subsequent PCR. For relative quantification, we applied the 2-ΔΔCq method. Agarose gel electrophoresis was used to confirm the specificity of the amplified PCR products. To quantify mRNA levels of specific genes in the oocyte, transcript levels were calculated in relation to porphobilinogen deaminase (PBGD) and β-actin (ACTB). To ensure result integrity, an additional housekeeping gene, 18S rRNA, was used as an internal standard.

Results
=======

We observed upregulation of all genes involved in 'positive regulation of transcription, DNA-dependent', 'positive regulation of transcription from RNA polymerase II promoter', 'positive regulation of gene expression', 'positive regulation of macromolecule metabolic process' before IVM as compared to transcriptional profile analyzed after IVM.

### Microarray

Whole transcriptome profiling by Affymetrix microarray allowed us to analyze the oocyte gene expression changes after *in vitro* maturation in relation to freshly isolated oocyte, before *in vitro* procedure (*in vivo*). By Affymetrix^®^ Porcine Gene 1.1 ST Array we examined expression of 12258 porcine transcripts. Genes with fold change higher than abs ([@b2-mmr-21-03-1537]) and with corrected P-value lower than 0.05 were considered as differentially expressed. This set of genes consisted of 419 different transcripts.

DAVID (Database for Annotation, Visualization and Integrated Discovery) software was used for extraction of enriched GO BP terms. Up and downregulated gene sets were subjected to DAVID searching separately and only gene sets where adj. P-value were lower than 0.05 were selected, as previously described ([@b17-mmr-21-03-1537]). We find that 28 genes that belong to 'positive regulation of transcription, DNA-dependent', 'positive regulation of gene expression', 'positive regulation of macromolecule metabolic process' and 'positive regulation of transcription from RNA polymerase II promoter' GO BP terms were significantly represented in downregulated gene set. This set of genes was subjected to hierarchical clusterization procedure and presented as heatmaps ([Fig. 1](#f1-mmr-21-03-1537){ref-type="fig"}). Fold changes in expression, Entrez gene IDs and adjusted P. values of genes belonging to selected GO BP were shown ([Table II](#tII-mmr-21-03-1537){ref-type="table"}).

To further investigate the changes within chosen GO BP terms we measured the enrichment levels of each selected GO BP terms. The enrichment levels were expressed as z-score and presented as circular visualization ([Fig. 2](#f2-mmr-21-03-1537){ref-type="fig"}).

In Gene Ontology database genes that formed one particular GO group can also belong to other different GO term categories. For this reason, we have explored the gene intersections between selected GO BP terms. The relation between those GO BP terms was presented as circle plot ([Fig. 3](#f3-mmr-21-03-1537){ref-type="fig"}) as well as heatmap ([Fig. 4](#f4-mmr-21-03-1537){ref-type="fig"}).

STRING interaction network was generated among chosen differentially expressed genes belonging to each of the selected GO BP terms. Using such prediction method provided us with a molecular interaction network formed between protein products of studied genes ([Fig. 5](#f5-mmr-21-03-1537){ref-type="fig"}). Finally, we investigated the functional interactions between chosen genes with REACTOME FIViz app to Cytoscape 3.6.0 software. The results were shown in [Fig. 6](#f6-mmr-21-03-1537){ref-type="fig"}.

RT-qPCR was used to validate the results of microarray analysis. The results were presented in a form of a bar graph ([Fig. 7](#f7-mmr-21-03-1537){ref-type="fig"}).

Overall, the direction of changes was confirmed in every example. However, the scale of changes in levels of gene expression varied between the methods. In examples such as: *APP, NR5A1, MEF2C, INSR, EGR1* and *ECE1* the difference was rudimental. However, in some genes (*WWTR1, VEGFA, PSMB4, INGBA, IHH, FOS, ESR1, EGR2, ENDRA, CCND2, AR*) the variation between the methods was major. The rest of the genes presented moderate variation between the microarray and RT-qPCR results.

Light microscope observation of H&E stained sections revealed the normal histological structure of ovaries ([Fig. 8](#f8-mmr-21-03-1537){ref-type="fig"}). The follicles in different stages of development were present in each of analyzed sections.

Discussion
==========

Heat maps show the expression of genes which belong to the category of 'positive regulation of transcription, DNA-dependent', 'positive regulation of transcription from RNA polymerase II promoter', 'positive regulation of gene expression' and 'positive regulation of macromolecule metabolic process' from GO. BP database. We have found abundant differences in the expression of genes: *FOS, VEGFA, ESR1, AR, CCND2, EGR2, ENDRA, GJA1, INHBA*. These genes were upregulated in porcine oocytes before IVM as compared with post-IVM expression analysis.

In the complexity of genes up- and downregulated in mammalian cumulus-oocyte-complex cross-talk, we have tried to distinguish these, which are differentially expressed in the *in vitro* oocyte culture in comparison to development *in vivo*. Investigation of transcriptomic profiles of oocyte and CCs separately is a very demanding challenge, requiring deep knowledge of factors acting bi-directionally and expressed exceptionally in particular cell type. Regassa *et al* ([@b7-mmr-21-03-1537]) analyzed transcriptome profile from oocyte and CCs samples in bovine ovaries. They detected multiple genes in germinal vesicle and in metaphase II oocytes, reflecting their different expression patterns, in accordance to presence, or absence of accompanying cumulus cells. This study revealed, that a total of 265 transcripts expressed differentially between oocytes cultured with and without CCs, of which 217 and 48 were over expressed in the former and the later groups, respectively. Authors concluded, that the presence or absence of cumulus cells\' factors during bovine oocyte maturation can have a significant influence on transcript abundance, showing the dominant importance of molecular cross-talk between oocytes and their corresponding CCs. This leads us to the conclusion, that 'bare' oocyte, even matured *in vitro* in cumulus-like conditions, can express differently than one encapsulated in cumulus complex. Moreover, it might express some GCs specific factors in conditions of granulosa crosstalk deficiency. Therefore, it is a very challenging request and limit of our study, to differentiate cell-specific transcriptome and to conclude, that particular gene is expressed in oocyte exceptionally, especially in *in vitro* culture of isolated oocyte.

Moreover, considering the above, in the present study we performed a microarray approach-analyzed porcine oocyte transcriptome and found abundant expression of multiple genes, including *FOS, VEGFA, ESR1, AR, CCND2, EGR2, ENDRA, GJA1, INHBA, IHH, INSR, APP, WWTR1, SMARCA1, NFAT5, SMAD4, MAP3K1, EGR1, RORA, ECE1, NR5A1, KIT, IKZF2, MEF2C, SH3D19, MITF* and *PSMB4*.

These genes were downregulated after *in vitro* oocyte maturation, what might indicate decreased potential of the cell to develop in an environment different than physiological. We will discuss only the most abundant differences in expression of oocyte genes before and after IVM procedure.

The strongest inhibitory effect after *in vitro* maturation of oocytes referred to transcription factor FBJ-murine osteosarcoma viral oncogene homolog (FOS). It refers to all ontology groups analyzed in recent study. Defined also, as Fos Proto-Oncogene or AP-1 Transcription Factor Subunit, it belongs to the Fos family, comprising of c-Fos, FosB and its smaller splice variants, Fra-1 and Fra-2. It is the part of the SMAD3/SMAD4/JUN/FOS complex and it forms AP1 promoter site due to response to TGF-β ([@b18-mmr-21-03-1537]). It binds to the regulatory regions of numerous genes ([@b19-mmr-21-03-1537],[@b20-mmr-21-03-1537]). Specific functions of Jun-Fos proteins depend on posttranslational modifications, selective dimerization between family members, and protein-protein interactions with other regulatory molecules ([@b21-mmr-21-03-1537]). It plays a critical role in regulating the development of cells destined to form and maintain the skeleton. It was proved by Johnson *et al* ([@b22-mmr-21-03-1537]), that the c-fos proto-oncogene has been admitted as a central regulatory component of the nuclear response to mitogens and other extracellular stimuli in mice. The homozygous mutants showed diminished placental and fetal weights and significant loss of viability at birth. There were multiple defects observed, like foreshortening of the long bones, ossification of the marrow space, and absence of tooth eruption, delayed or absent gametogenesis, lymphopenia, and altered behavior. The above indicated that c-Fos was involved in the development and function of several distinct tissues. Moreover, in humans, c-Fos gene transcripts were localized significantly more abundant in fetal amniotic and chorionic cells, what suggested that these gene may be related to embryo-derived cells, whose primary functions are protection and nourishment of the fetus ([@b23-mmr-21-03-1537]). The analysis of porcine ovaries, obtained by Rusovici *et al* ([@b21-mmr-21-03-1537]), suggests that although most AP-1 factors are present throughout the follicular cycle, specific Jun/Fos proteins are more characteristic for a particular stage of development than for another. The authors found c-Fos, FosB and Fra-1, Fra-2 in all follicular cell compartments, also in oocyte nucleus, in which being present throughout whole follicle development, but the last staining could be nonspecific due to technical limitations. Nevertheless, a study conducted by Hattori *et al* ([@b24-mmr-21-03-1537]), showed the presence of c-Fos mRNA in porcine oocytes as well. There is limited data concerning AP1/FOS in folliculogenesis and in ovulation, though it may be involved in many cellular processes, e.g. regulation of steroidogenesis or granulosa cell proliferation. It has been found to be induced by FSH in pig oocyte culture after 1 h, what was consistent with rat studies, but progressively fell over the whole culture period ([@b25-mmr-21-03-1537]).

The second most significant expression decline was observed in VEGFA. This gene is downregulated in all of the ontology groups in our study, after IVM procedure. VEGF gene codes a heparin-binding growth factor specific for vascular endothelial cells and it induces angiogenesis *in vivo* ([@b26-mmr-21-03-1537]). It has been purified from bovine pituitary follicular cells in 1989 and proved to be mitogenic factor for capillary endothelial cells ([@b27-mmr-21-03-1537]). The gene itself, is a member of platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family. This potent factor occurs in five isoforms that rise from alternative splicing of the same gene, and the above have various metabolic effects ([@b28-mmr-21-03-1537]).

The known, basic functions of vascular endothelial growth factor A (VEGFA) are: The regulation of cell growth and differentiation; the stimulation of angiogenesis and neovascularization in tissues and organs, inhibition of apoptosis, promotion of cell migration and vascular permeability ([@b29-mmr-21-03-1537]). It is essential for both physiological and pathological vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. VEGFA has also been widely studied because of its important role in follicle development. It has been proven, that the growth of antral follicles is associated with increased density of blood vessels within the theca cell layers ([@b30-mmr-21-03-1537]). Moreover, the injection of VEGF gene directly into gilts\' ovaries, increased the levels of mRNA expression of VEGF 120 and VEGF 164 isoforms in the granulosa cells and VEGF protein level in the follicular fluid. This resulted in the increase in number of preovulatory follicles, indicating, that angiogenesis is an important factor in the development of ovulatory follicles ([@b30-mmr-21-03-1537]). However, since the expression of VEGFA has also been localized in nonvascular follicles and cells, influence on follicular development through nonangiogenic mechanisms is debated ([@b31-mmr-21-03-1537]). It is unknown, if oocyte originated VEGFA has an influence on surrounding cells, but Bui *et al* ([@b32-mmr-21-03-1537]) published data confirming, that VEGF supplementation improves the meiotic and developmental competence and fertilization ability of oocytes derived from 0.3--5 mm porcine follicles, at adequate concentrations during IVM. This might indicate, that VEGF has to be secreted locally (by GCs or oocyte), before vascularization process occurs, to increase growth and developmental competence of the oocyte. In addition, its levels do not increase, until antrum formation. Consistent with previous studies ([@b33-mmr-21-03-1537],[@b34-mmr-21-03-1537]), in the culture of monkey follicles, Xu *et al* ([@b35-mmr-21-03-1537]) revealed that VEGF is increased markedly in activated, growing follicles (theca and GCs close to the oocyte), but not in primordial and preantral ones. The hypothesis concludes, that VEGF-dependent antrum formation is a result of hypoxic state of the growing follicle, and increasing need for oxygen and substrates for developing oocyte ([@b36-mmr-21-03-1537]).

Besides FOS and VEGFA, there was significant reduction in expression of AR, EGR2 and INHBA in all four ontology groups observed.

It has been distinctly proven, that androgen receptor (AR) is one of the essential players in reproductive system in mammals ([@b37-mmr-21-03-1537]). AR is expressed in various reproductive tissues, including, various ovarian cells and neuroendocrine ovarian-pituitary-hypothalamus axis. Reproductive phenotypes examined in androgen receptor knock out mice (ARKO) showed disturbances explainable by granulosa cells AR expression, including premature ovarian failure (POF), subfertility with longer estrous cycles, fewer ovulated oocytes, more preantral and atretic follicles, fewer antral follicles and fewer corpora lutea. In addition, *in vitro* growth of follicles was slower than in control wild-type animals ([@b38-mmr-21-03-1537]). Lenie and Smitz analyzed mouse *in vitro* folliculogenesis model and proved the importance of AR to normal follicle maturation. Treatment with anti-androgenic compounds reduced follicle growth during the preantral phase and oocyte meiotic maturation in response to human hCG was arrested ([@b39-mmr-21-03-1537]). Therefore, interestingly, oocytes also appear to benefit from androgens. Li *et al* ([@b40-mmr-21-03-1537]) revealed that testosterone positively contributes to porcine oocyte meiotic resumption in culture system containing a low dose of hypoxanthine. AR apparently significantly contributes to testosterone-induced mitogen-activated protein kinase activation and germinal vesicle breakdown ([@b38-mmr-21-03-1537],[@b40-mmr-21-03-1537]). In human model AR has been widely investigated in polycystic ovary syndrome (PCOS) patients, in whom there are high androgen levels observed and diminished oocyte developmental competence. Despite the fact, that PCOS is a heterogenous condition, that has different diagnostic criteria worldwide, the AR gene is the X-linked candidate for follicle arrest and maturation disorders. Van Nieuwerburgh *et al* ([@b41-mmr-21-03-1537]) suggested that the gene\'s CAG repeat polymorphism is associated with a PCOS phenotype. They reported, shorter CAG repeats in the AR gene, that appear to enhance androgenicity in PCOS.

The next significantly downregulated expression concerns an EGR2 gene-protein also termed Krox20. The early growth response (EGR) family of zinc finger transcription-regulatory factors influences critical genetic programs in cellular growth, differentiation, and function ([@b42-mmr-21-03-1537],[@b43-mmr-21-03-1537]). There are four EGR members, EGR1, EGR2, EGR3, and EGR4 and each of them have specific biological functions, for example inflammation, immune tolerance and glucose homeostasis ([@b44-mmr-21-03-1537]). It was extensively examined in the context of autoimmunity, being a potent negative regulator of adaptive immune responses ([@b45-mmr-21-03-1537]). The gene products are induced in response to multiple extracellular signals, such as growth factors, hypoxia, cytokines and mechanical forces associated with injury and cellular stress ([@b46-mmr-21-03-1537]). EGR2 gene is highly expressed in a population of migrating neural crest cells in mice and is critical for peripheral nerve myelination in Schwann cells ([@b47-mmr-21-03-1537]). It also has a specific function in the regulation of hindbrain segmentation, stabilization of long-term potentiation, neural plasticity, learning and memory ([@b48-mmr-21-03-1537]), and EGR2-null mice died early, in the embryonic stage, due to defective myelination ([@b45-mmr-21-03-1537],[@b49-mmr-21-03-1537]). The interesting research by Fang *et al* ([@b46-mmr-21-03-1537]), showed, that it also may take part in tissue remodeling and wound healing processes, due to upregulation of multiple genes associated with these above. They revealed EGR2, as a functionally distinct transcription factor that was both necessary and sufficient for TGF-β-induced profibrotic responses. These findings suggested that EGR2 plays a role in the pathogenesis of fibrosis. Moreover EGR2 has been suggested to participate in multiple extracellular signals, including adipogenesis and carcinogenesis ([@b50-mmr-21-03-1537]) and it was shown to control adipocyte differentiation, which potentially links to insulin resistance ([@b51-mmr-21-03-1537]). In ovary, EGR2 was investigated, as an intra-ovarian factor, part of a novel signaling axis comprising of gonadotropins-EGR2-IER3, regulating the survival of granulosa cells during folliculogenesis in rats and humans ([@b52-mmr-21-03-1537]). It was also found in the article above, to regulate the expression of myeloid cell leukemia 1 (MCL-1), which belongs to the BCL-2 family of proteins regulating cell survival. It is rather EGR3, that localizes to chromosomes during meiotic progression and it seems to be dispensable during oocyte maturation in mice ([@b43-mmr-21-03-1537]).

INHBA is the protein also known as inhibin beta A or follicle-stimulating hormone-releasing protein (FRP), and is encoded by the INHBA gene ([@b53-mmr-21-03-1537]). The resultant preprotein is a member of the transforming growth factor β (TGF-β) superfamily and is proteolytically modified to build a subunit of the dimeric activin and inhibin protein complexes. Inhibin β A (INHBA) forms a disulfide-linked homodimer known as activin A, which is also a well-known factor in the hypothalamic-pituitary-gonadal axis ([@b54-mmr-21-03-1537]). Activin A is also proved to play role during embryogenesis and in specific differentiation processes, such as hematopoiesis and osteogenesis ([@b55-mmr-21-03-1537]). INHBA gene is overexpressed in various types of neoplasms, including colorectal, pancreatic, skin and lung cancer ([@b56-mmr-21-03-1537]), but also presents cytostatic and proapoptotic signaling in human melanoma cells ([@b57-mmr-21-03-1537]). According to Locci *et al* ([@b58-mmr-21-03-1537]), it is proven, that activin A programs the differentiation of human follicular helper T cells, which play a role in protective antibody responses and autoimmune diseases, using SMAD2 and SMAD3 signaling pathways. High expression of INHBA has also been correlated with developmental competence of oocytes and proposed, among others, as predictor of embryo quality in women and in animal models ([@b7-mmr-21-03-1537],[@b59-mmr-21-03-1537],[@b60-mmr-21-03-1537]). Little is known about specific roles of inhibins (activin A as well) in early stages of folliculogenesis, but mouse and human models present it, as an important factor for cell proliferation (germ and somatic) and follicular assembly as well ([@b61-mmr-21-03-1537]). Myers *et al* ([@b62-mmr-21-03-1537]) showed, that the absence of inhibin (but in this paper-particularly inhibin A) induced more granulosa cell-derived activin signaling and oocyte-derived GDF9, reducing Kitl expression in granulosa cells, which in turn influence oocyte growth and contributes to the small oocyte phenotype.

ENDRA and GJA1 expression was markedly reduced in our post-IVM expression analysis. They belong to only one ontology group-the positive regulation of macromolecule metabolic process.

ENDRA is a endothelin-1 receptor type A, also indexed as ETA, is a peptide that plays a role in potent and long-lasting vasoconstriction. There are two receptors, ETA and ETB (the endothelin-1 receptor type B), which are members of the family A G-protein-coupled receptors ([@b63-mmr-21-03-1537]). ENDRA signaling is known to be involved in cardiovascular and craniofacial development, and mice deficient in Endothelin1/Ednra signaling present malformation of an aortic arch and outflow anomalies, which are attributed to cardiac neural crest mesenchymal cell defects ([@b64-mmr-21-03-1537]). Kawamura *et al* ([@b65-mmr-21-03-1537]) demonstrated, that in periovulatory mice ovaries, there is an increase in the expression of endothelin-1 and one of its receptors endothelin receptor type A (EDNRA). They also presented the ability of endothelin-1 to promote GVBD of preovulatory oocytes by using *in vitro* and *in vivo* models, analyzing communication between cumulus cells and oocytes. In addition, the experimental study by Cui *et al* ([@b66-mmr-21-03-1537]) on supplementation of endothelin-1 to culture medium with human oocytes, presented significant promotion of oocyte maturation via connexin 26 (Cx26) gene expression.

GJA1-Gap junction alpha-1 protein, also known as connexin 43 (Cx43)-is a component of gap junctions, which allow cell to cell communications, providing a route for the diffusion of low molecular weight materials from cell to cell, regulating proliferation, differentiation and cell death ([@b67-mmr-21-03-1537]). It is detected in most cell types, and a major protein responsible for synchronized heart contraction ([@b68-mmr-21-03-1537]). It is also expressed in in cumulus cells, participating in connexons with other cumulus granulosa cells or the oocyte. It regulates oocyte meiosis resumption, and lower levels of GJA1 in cumulus cells are beneficial for oocyte maturation ([@b69-mmr-21-03-1537]). Li *et al* ([@b70-mmr-21-03-1537]) evaluated cumulus GJA1 gene expression levels according to maturation of the oocyte, fertilization and embryo development. They found GJA1 to be a promising oocyte maturation predictor, but not a fertilization and embryo morphology marker, as indicated in previous studies ([@b71-mmr-21-03-1537],[@b72-mmr-21-03-1537]).

ESR1 gene, coding estrogen receptor alpha is highly conserved among the vertebrates, and is nuclear, ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription ([@b73-mmr-21-03-1537]). The 5′ region of the gene contains multiple promoters responsible for tissue-specific gene expression. ERs form homo- and heterodimers and, when activated, can bind to specific estrogen response elements (EREs) in genes, to mediate transcription of various developmental and homeostatic pathways ([@b74-mmr-21-03-1537]). During sex differentiation in human, when ESR1 is bound by its main ligand, estradiol, the whole complex converts to a form binding to nuclear components, starting the activation or repression of numerous genes involved in development, organization and other functions. It is fundamental in maintaining female phenotype of the endocrine somatic cells of the ovary and development of interstitial compartment cells, keeping the integrity of female sex differentiation ([@b75-mmr-21-03-1537]). ESR1 female knockout homozygous mice appear to develop testis-like features with Leydig cell-like changes to interstitial cells with symptoms of sex reversal in the aspect of morphology and function ([@b76-mmr-21-03-1537]). In the human ovary immunoreactivity for ESR1 was found in thecal, interstitial, and germinal epithelium cells, moreover it is also noticeable in adrenal cortices, kidneys mammary gland, bone, heart, hypothalamus, pituitary gland, liver, lung, spleen, adipose tissue and significantly in epithelial, stromal, and muscle uterine cells ([@b77-mmr-21-03-1537]). ESR1 plays an important role in a variety of tissues and structures, like reproductive, central nervous, skeletal, and cardiovascular systems ([@b78-mmr-21-03-1537],[@b79-mmr-21-03-1537]). In addition, there are two splice variants resulted from alternative splicing of an ESR1, presenting different tissue-specific manners. ESR1 splice variants were detected in nuclei of granulosa cells of growing follicles at all stages from primary to mature follicles, interstitial gland, theca cells and germinal epithelium cells ([@b80-mmr-21-03-1537]). It is widely known, that ESR1 is extensively disputed in relation to breast cancer therapy and valuable use of selective estrogen receptor modulators ([@b81-mmr-21-03-1537]). Artini *et al* ([@b82-mmr-21-03-1537]), interestingly analyzed human and mouse cumulus cells samples and concluded, that the downregulation of ESR1 could be related to oocyte competence and is likely to be the driver of expression changes highlighted in the PI3K/AKT pathway.

Cyclin D2 (CCND2) is also downregulated after IVM procedure in porcine oocytes. In general, D-type cyclins are considered as ultimate recipients of mitogenic and oncogenic signals and present specific over-expression in some malignancies in humans. They promote G1/S transition during cell cycle progression, and the action is based on binding to cyclin-dependent kinases, increasing retinoblastoma protein phosphorylation and relieving inhibition of the transcription factor E2F ([@b83-mmr-21-03-1537]). CCND2 is expressed mainly in granulosa cells in response to FSH in the ovary, and cyclin D2 deficient mice present sterility due to lack of proliferative action of GCs and resulting in follicle arrest ([@b84-mmr-21-03-1537]). Han *et al* ([@b85-mmr-21-03-1537]) reveled, that in rat ovaries, FSH rapidly increased CCND2 expression through both the cAMP/PKA and PI3K/PDK1/Akt signaling pathways, but also enhanced cAMP-mediated CCND2 degradation through a ubiquitin-proteasome pathway. Moreover, the inquiring study on infant mice ovaries published by François *et al* ([@b86-mmr-21-03-1537]), showed, that cyclin D2 expression is influenced by FSH, but in particular concentrations. Low concentrations were inducing CCND2, resulting in GCs proliferations, while high levels of FSH were unable to stimulate cyclin D2-dependent follicular growth, but supporting steroidogenesis. In the study above, it was suggested, that since the paracrine oocyte action plays a significant role in development of ovarian follicles, it would be of interest to determine the possible contribution of the oocyte in the function of the infantile ovary. Cyclin D2 could be one of the factors explaining this process.

Overall, the study has provided us with a plethora of genes that could potentially become new markers of oocyte *in vitro* maturation associated with regulation of transcription and macromolecule metabolism. However, it needs to be noted that it is an entry level transcriptomic study, which will need further validation on protein level, followed by further *in vivo* studies to gain clinical significance. Despite that, this research might serve as a point of reference for future studies and possible clinical approaches.
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![Circular visualization of gene-annotation enrichment analysis. The outer circle presents a scatter plot for each log FC term of the assigned genes. Red circles indicate upregulation and blue circles indicate downregulation. The inner circle represents the Z-score and the size/colour of the bar corresponds to its value.](MMR-21-03-1537-g01){#f2-mmr-21-03-1537}
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![Heatmap presenting occurrence between genes that belong to 'positive regulation of transcription, DNA-dependent', 'positive regulation of gene expression', 'positive regulation of macromolecule metabolic process' and 'positive regulation of transcription from RNA polymerase II promoter' GO BP terms. Red coloring indicates the gene occurrence in the indicated GO BP Term. Colour intensity is correlated with the number of GO BP terms that selected genes belonged to. GO, gene ontology; BP, biological process.](MMR-21-03-1537-g03){#f4-mmr-21-03-1537}

![STRING-generated interaction network among differentially expressed genes belonging to the 'positive regulation of transcription, DNA-dependent', 'positive regulation of gene expression', 'positive regulation of macromolecule metabolic process' and 'positive regulation of transcription from RNA polymerase II promoter' Gene Ontology biological process terms. The intensity of the edges indicates the strength of interaction score.](MMR-21-03-1537-g04){#f5-mmr-21-03-1537}
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![Comparison of RT-qPCR and microarray results. RT-qPCR, reverse transcription-quantitative PCR.](MMR-21-03-1537-g06){#f7-mmr-21-03-1537}

![Photomicrograph representing the sections of ovaries stained with hemotoxylin and eoesin. All images present follicles in various stages of development. The description of each arrow and number is represented in brackets. (A) Primordial and primary follicles. Tissue sections exhibiting: (B) Primordial follicles and primary follicles, and (C) primary oocytes, zona pellucida, granulosa cells, theca cells, follicular cells, cortical stroma and tunica albuginea. (D) Secondary follicle. Tissue sections exhibiting: (E) secondary follicles, and (F) primary oocytes, zona pellucida, antrum, granulosa cells, theca cells and theca externa. (G) Graafian follicle. Tissue sections exhibiting: (H) Graafian follicles, and (I) secondary oocytes, zona pellucida, corona radiata, cumulus oophorus, antrum, granulosa cells and theca externa. 1, primordial follicle; 2, primary follicle; 3, 7 and 12, primary oocyte; 4, 13 and 20, zona pellucida; 5, 15 and 24, granulosa cells; 6 and 16, theca cells; 8, follicular cells; 9, corticol stroma; 10, tunica albuginea; 11, secondary follicle; 14 and 23, antrum; 17 and 25, theca externa; 18, Graafian follicle; 19, secondary oocyte; 21, corona radiata; 22, cumulus oophorus.](MMR-21-03-1537-g07){#f8-mmr-21-03-1537}

###### 

Oligonucleotide sequences of the primers used for reverse transcription-quantitative PCR analysis.

  Gene       Accession number   Primer sequence (5′-3′)          Product size (bp)
  ---------- ------------------ -------------------------------- -------------------
  APP        P79307             F: CATCGCTTACAAACTCGCCA          160
                                R: TGCCAAGAAGTCTACCCTGA          
  AR         NP_999479          F: TGGTGCAATCATTTCTGCTG          153
                                R: ACTTTCCACCCCAGAAGACC          
  CCND2      Q8WNW2             F: ACGTCGGTGTTGGTGATCC           154
                                R: CCACTGACTTCAAGTTCGCC          
  ECE1       HGNC:3146          F: GTAATGTTAGCAGCGCCGTT          110
                                R: GAGAAGGTGCTGACGGGATA          
  EDNRA      NP_999394          F: AGGTGTTCACTGAGGGCAAT          168
                                R: TGCCACGTCAAAATTCATGGA         
  EGR1       HGNC:3238          F: CCACTAGAACCTTCTCGTTATTCA      103
                                R: AGCGCCTTCAACCCTCAG            
  EGR2       NP_001090957       F: GCTGGCACCAGGGTACTG            154
                                R: CGGAGATGGCATGATCAAC           
  ESR1       Q29040             F: TTCCTGTCCAGGAGCAAGTT          155
                                R: AAGAGGGTGCCAGGATTTTT          
  FOS        NP_001116585       F: CAGATCGGTGCAGAAGTCCT          159
                                R: ATGATGTTCTCCGGCTTCAA          
  GJA1       NP_001231141       F: GGGCAGGGATCTCTTTTGC           150
                                R: CAAGGTGAAAATGCGAGGGG          
  IHH        NP_001231399       F: CACACGTGCCCCACTCTC            134
                                R: GCTTCGACTGGGTGTATTACG         
  IKZF2      HGNC:13177         F: AGGAGGTACATGGTGACTCA          174
                                R: CTCACAGGACACCTCAGGAC          
  INHBA      P03970             F: TCAGGAAGAGCCAGATTTCG          151
                                R: AGGGCGGAAATGAATGAACT          
  INSR       HGNC:6091          F: GTCGGTGACTCTCTCTGGAC          160
                                R: CACTTCTTCCGACATGTGGT          
  KIT        NP_001037990       F: ACAGCCTAATCTCATCGCCA          152
                                R: CGCCTGGGATTTTCTCTTCG          
  MAP3K1     HGNC:6848          F: CTACATTCTTCTGCCCAGATTG        150
                                R: TTCAGAAAACAGTATAAAAGATGAAGA   
  MEF2C      NP_001038005       F: TTTTGCTTGCATATTCTTGTTCA       168
                                R: CCTGGTGTAACACATCGACCT         
  MITF       NM_001315782       F: CTGTTCCCGTTGCAACTTTC          163
                                R: CAATCACAACTTGATTGAACGAA       
  NFAT5      HGNC:7774          F: GTTGGCCTGGCTGACTTATG          157
                                R: GGAGGTACAATGAACCAGCTACA       
  NR5A1      P79387             F: GGTCAGCTCCACCTCCTG            150
                                R: GTCTTCAAGGAGCTGGAGGT          
  PSMB4      NP_001231384       F: ACGTAACCCAGGAAGCTCTC          165
                                R: GGTGATTGATGAGGAGCTGC          
  RORA       HGNC:10258         F: CATGAGCGATCTGCTGACAT          152
                                R: TATGCTAGCCCCGATGTCTT          
  SH3D19     HGNC:30418         F: GCTCTGTTATTATGTCTCCAGCC       154
                                R: ATCTTCCCCGCAGTCTTCG           
  SMAD4      Q9GKQ9             F: TGTTTTAATTCATTTTTGTGAAGATCA   150
                                R: AACCACAAATGGAGCTCACC          
  SMARCA1    HGNC:11097         F: TTCCTTGGGACCTTATAGCC          164
                                R: AGAGAGGCATTACGTGTCAGC         
  VEGFA      NP_999249          F: TCTCGATTGGACGGCAGTAG          154
                                R: CTCTCTTGGGTGCATTGGAG          
  WWTR1      HGNC:24042         F: ATTGATGTTCATGGGTGTGG          152
                                R: ATGGGGGACCATATCATTCA          
  ACTB       DQ845171           F: GGGAGATCGTGCGGGACAT           141
                                R: CGTTGCCGATGGTGATGAC           
  PBGD       NM_001097412       F: GAGAGTGCCCCTATGATGCTAT        214
                                R: GATGGCACTGAACTCCT             
  18S rRNA   AB117609           F: GTGAAACTGCGAATGGCTC           105
                                R: CCGTCGGCATGTATTAGCT           

F, forward; R, reverse.

###### 

Gene symbols, fold changes on expression, Entrez gene IDs and adjusted P-values of the genes studied.

  Gene      Fold-change   Adjusted P-value   Entrez Gene ID
  --------- ------------- ------------------ ----------------
  APP       0.324139      0.005602           351
  AR        0.105986      0.000138           367
  CCND2     0.121809      0.000179           894
  ECE1      0.395388      0.001178           1889
  EDNRA     0.166939      0.001854           1909
  EGR1      0.376128      0.005477           1958
  EGR2      0.165504      0.00795            1959
  ESR1      0.08163       0.000522           2099
  FOS       0.052794      4.74E-05           2353
  GJA1      0.206907      0.000108           2697
  IHH       0.304996      0.000551           3549
  IKZF2     0.431872      0.002983           22807
  INHBA     0.24126       0.000148           3624
  INSR      0.316016      0.001913           3643
  KIT       0.430444      0.002556           3815
  MAP3K1    0.368765      0.024748           4214
  MEF2C     0.453593      0.003964           4208
  MITF      0.49166       0.00633            4286
  NFAT5     0.344889      0.013145           10725
  NR5A1     0.425153      0.001889           2516
  PSMB4     0.493702      0.000939           5692
  RORA      0.383924      0.021554           6095
  SH3D19    0.488128      0.046513           152503
  SMAD4     0.367802      0.001239           4089
  SMARCA1   0.329141      0.014759           6594
  VEGFA     0.069689      0.001913           7422
  WWTR1     0.327202      0.000254           25937
